资讯
相关内容-
06-12 20:27:41
-
06-12 20:19:17
-
06-12 20:07:41
-
06-12 20:05:31
-
06-12 19:57:51
-
06-12 19:02:18
-
06-12 18:56:57
-
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugat06-12 18:26:23
-
06-12 18:15:13
-
06-12 18:12:23
-
06-12 17:54:03
-
06-12 17:53:15
-
06-12 17:52:22
-
06-12 17:51:49
-
06-12 17:42:32
-
06-12 17:41:48
-
06-12 17:41:03
-
06-12 17:40:13
-
06-12 17:39:22
-
06-12 17:38:03
-
06-12 17:37:58
-
06-12 17:36:24
-
06-12 17:34:22
-
06-12 17:33:40
-
06-12 17:32:11